Skip to main content
SpringerLink
Log in

Benefit-risk balance of birth-control pills affirmed

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Health Canada.Yasmin and Yaz (drospirenone): Updated information on increased risk of blood clots. Internet Document: 5 Dec 2011. Available from: URL: http://www.hc-sc.gc.ca

  2. Bayer HealthCare Pharmaceuticals Inc.Bayer’s Drospirenone-containing Combination Oral Contraceptives: FDA Advisory Committees Affirm Positive Benefit-risk Profile and Recommend an Update of Labels to Reflect Information From Available Studies. Media Release: 8 Dec 2011. Available from: URL: http://www.bayer.com

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Benefit-risk balance of birth-control pills affirmed. React. Wkly. 1383, 2 (2012). https://doi.org/10.2165/00128415-201213830-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201213830-00002

Keywords

Search

Navigation